Search
for
Sort by
Research 421–450 of 1000+
- Erosive Pustular Dermatosis: A Manifestation of Immunosenescence A Report of 8 Cases
- Progestogens in menopausal hormone therapy
- 17β-Estradiol Increases APE1/Ref-1 Secretion in Vascular Endothelial Cells and Ovariectomized Mice: Involvement of Calcium-Dependent Exosome Pathway
- Androgens in cervical cancer: Their role in epidemiology and biology
- Hormonal interventions in skin wounds – a mini review
- Association of hair dye use with circulating levels of sex hormones in premenopausal Japanese women
- Are South African Wild Foods the Answer to Rising Rates of Cardiovascular Disease?
- Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- Effect of the Hypoxic Chamber Training Series on Skin Characteristics of Overweight and Obese Women
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Prolonged use of finasteride-induced gonadal sex steroids alterations, DNA damage and menstrual bleeding in women
- Dietary Collagen Supplementation as a Strategy for Skin Health: A Narrative Review of Clinical Effects on Skin, Hair, Nails, and Wound Healing
- Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments
- Understanding the Secular Decline in Testosterone: Mechanisms, Consequences, and Clinical Perspectives
- Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis
- Reproduction of the human relevant potency threshold (HRPT) for estrogen receptor alpha agonism in an inference performance screen for ICCVAM’s regulatory scientific confidence framework
- Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment
- Oral Finasteride (5 mg and 2 mg) versus Topical Minoxidil 5% in Female Pattern Hair Loss
- The Impact of Chemotherapy on the Nutritional Status of Breast Cancer Patients
- The Effects of Single Testosterone Administration and Stress Induction on Steroid Hormone Levels in Hair
- Investigating the role of various extracellular matrix in androgenetic alopecia: Insights from immunostaining and quantitative analysis – A pilot study
- Coexistence of Malassezia Species and Microsporum canis in the Lesions of Adult with Tinea Capitis
- Multifocal alopecia of the scalp, axillae, and body
- Dihydrotestosterone induces arterial stiffening in female mice
- Levels of sex steroids in lung tissues of patients with non‑small cell lung cancer after COVID‑19 of different severity
- FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women
- Management of Breast Pain
- Laparoscopic adrenalectomy – a cure for male pattern baldness
- Dihydrotestosterone and 5α-Reductase